Company name
2022Founder
George Scangos Dr. George Scangos has decades of experience building and leading biopharmaceutical companies, most recently as the founding President, CEO (2016 – 2023) and as a continuing board member of Vir Biotechnology. Under his leadership, Vir delivered life-saving therapies for Ebola and COVID-19 to millions of patients while also building a pipeline spanning five therapeutic areas.
Venture Partner
B.A. in biology
Ph.D. in microbiology